A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01) A61P 37/00 (2006.01)
Patent
CA 2621697
The invention relates to the use of agents that bind the complement protein C5 in the treatment of diseases associated with inappropriate complement activation and in particular in the treatment of myasthenia gravis.
La présente invention concerne l~utilisation d~agents se liant à la protéine C5 du complément dans le traitement de maladies associées à une activation inopportune du complément, en particulier dans le traitement de la myasthénie grave.
Hamer John
Weston-Davies Wynne
Evolutec Limited
Kirby Eades Gale Baker
Varleigh Limited
LandOfFree
Method of treating myasthenia gravis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating myasthenia gravis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating myasthenia gravis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1759135